Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Morristown NJ, Jacksonville FL, Chicago IL,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase 1, Phase 2, Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Salt Lake City UT,
Sponsor: Peel Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05329103

Phase 1, Recruiting

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

for
Malignant Abdominal Neoplasm, Malignant Head and Neck Neoplasm,
Location: Houston TX
Sponsor: Lucid Lane, Inc

Sex: All

Age: 18+

Code: NCT04963972

Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for
Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer,
Location: Houston TX, Beverly Hills CA, Santa Monica CA
Sponsor: Epkin

Sex: All

Age: 18+

Code: NCT06789172

Phase 1, Recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: Cleveland OH
Sponsor: Biocity Biopharmaceutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT06548672

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

for
Spinal Cord Injury, Spinal Cord Injuries,
Location: Jacksonville FL, Gainesville FL
Sponsor: North Florida Foundation for Research and Education

Sex: Male

Age: 18+

Code: NCT04460872

Phase 2, Recruiting

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

for
Solid Tumors
Location: Boston MA, Montreal, Durham NC, Toronto, Atlanta GA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05203172

Phase 4, Recruiting

Testicular Tissue Cryopreservation for Fertility Preservation

for
Cancer, Autoimmune Disorders
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT02972801

Recruiting

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05053867

Phase 3, Recruiting

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

for
Prostate Cancer,
Location: New York NY, Philadelphia PA
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT00503646

Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Atlanta GA, Louisville KY, Fairway KS, Dallas TX,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase 1, Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

for
Solid Tumors, ER+ Breast Cancer,
Location: Detroit MI, St Louis MO, Dallas TX, Salt Lake City UT
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT05490472

Phase 1, Phase 2, Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Providence RI, East Brunswick NJ, Toronto, Sarasota FL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05875168

Phase 1, Phase 2, Recruiting

Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy

for
Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT00026650

Recruiting

Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

for
Solid Tumor, Cancer Metastatic
Location: Woburn MA, Portland OR
Sponsor: CanWell Pharma Inc.

Sex: All

Age: 18 - 70+

Code: NCT04987112

Phase 1, Recruiting

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05178472

Recruiting

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: Austin TX, San Antonio TX, Scottsdale AZ
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT05094804

Phase 1, Phase 2, Recruiting

SNV4818 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, Philadelphia PA, Ottawa, Toronto,
Sponsor: Pikavation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06736704

Phase 1, Phase 2, Recruiting

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

for
Solid Tumors
Location: Cleveland OH, Nashville TN, St Louis MO, Houston TX,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT06386146

Phase 1, Phase 2, Recruiting

The Impact of COVID-19 on Pulmonary Procedures

for
COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT05022446

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial